dengu
viru
denv
complex
consist
serotyp
peopl
expos
primari
denv
infect
develop
robust
antibodi
respons
crossreact
serotyp
review
despit
extens
crossreact
individu
develop
long
term
protect
immun
homolog
serotyp
respons
primari
infect
inde
risk
progress
dhf
greater
secondari
compar
primari
infect
prevail
theori
explain
sever
dengu
secondari
infect
preexist
nonneutr
dengu
specif
antibodi
enhanc
denv
entri
replic
fcreceptorbear
cell
lead
higher
viremia
sever
diseas
antibodi
demonstr
enhanc
denv
cell
cultur
anim
model
dengu
pathogenesi
current
understand
antibodi
interact
denv
flavivirus
primarili
base
studi
util
mous
monoclon
antibodi
mab
review
denv
envelop
e
protein
principl
target
neutral
antibodi
antibodi
neutral
occur
block
critic
function
e
protein
includ
attach
host
cell
low
phdepend
fusion
viral
host
cell
membran
crystal
structur
e
protein
sever
flavivirus
solv
individu
subunit
e
protein
consist
three
betabarrel
domain
design
domain
edi
ii
edii
iii
ediii
nativ
protein
form
headtotail
homodim
mous
mab
bind
three
domain
denv
e
gener
character
although
neutral
mous
mab
map
three
domain
e
strongli
neutral
mab
recogn
epitop
later
ridg
strand
ediii
follow
primari
denv
infect
human
develop
antibodi
crossreact
serotyp
mainli
neutral
homolog
serotyp
respons
infect
review
studi
human
immun
sera
recent
human
monoclon
antibodi
demonstr
domin
antibodi
respons
crossreact
weakli
neutral
multipl
viral
antigen
includ
e
protein
premembran
prmm
protein
nonstructur
protein
recogn
human
humor
respons
nonetheless
studi
defin
actual
epitop
denv
recogn
typespecif
crossreact
human
antibodi
structur
level
compar
epitop
defin
use
mous
antibodi
target
dengu
typespecif
strongli
neutral
human
antibodi
remain
unknown
goal
studi
studi
two
subject
indepth
defin
major
antigen
epitop
recogn
antibodi
develop
follow
primari
human
denv
infect
defin
human
bcell
epitop
denv
key
step
toward
understand
antibodi
enhanc
inhibit
sever
denv
infect
provid
dr
robert
putnak
walter
reed
armi
institut
research
silver
spring
md
use
present
studi
recombin
envelop
protein
denv
serotyp
kindli
provid
dr
bethann
coller
hawaii
biotech
inc
recombin
protein
bind
conform
mab
xray
crystallographi
studi
demonstr
protein
retain
nativelik
structur
convalesc
denv
immun
sera
obtain
volunt
experienc
natur
denv
infect
travel
abroad
protocol
recruit
collect
blood
sampl
peopl
approv
institut
review
board
univers
north
carolina
chapel
hill
written
inform
consent
obtain
subject
collect
blood
elisa
plate
coat
ng
purifi
viru
ng
carbon
buffer
ph
hr
room
temperatur
incub
block
buffer
tbst
contain
skim
milk
normal
goat
serum
hr
human
immun
sera
hmab
serial
dilut
block
buffer
ad
hr
follow
alkalin
phosphataseconjug
goat
antihuman
igg
sigma
hr
final
pnitrophenyl
phosphat
substrat
sigma
ad
well
reaction
allow
develop
minut
record
optic
densiti
nm
spectrophotomet
denv
neutral
antibodi
measur
focu
reduct
neutral
test
frnt
vero
cell
use
flow
cytometrybas
neutral
assay
human
monocyt
cell
line
stabli
transfect
dcsign
previous
describ
peripher
blood
sampl
obtain
two
healthi
adult
donor
infect
denv
foreign
travel
dengu
neutral
profil
confirm
previou
primari
donor
donor
infect
tabl
donor
hmab
produc
previous
describ
bcell
produc
denv
specif
antibodi
identifi
screen
cultur
supernat
flow
cytometri
antibodi
bound
insect
cell
infect
donor
donor
secondari
screen
identifi
antibodi
bound
perform
elisa
previous
describ
denv
antibodi
escap
mutant
virus
select
infect
vero
cell
strain
presenc
hmab
concentr
estim
neutral
greater
infecti
viru
ie
dvc
dvc
equival
gc
copi
number
control
antibodi
treat
virus
repeatedli
passag
presenc
hmab
equival
denv
genom
copi
number
observ
mab
treat
control
sampl
passag
antibodi
pressur
escap
mutant
virus
plaqu
purifi
amplifi
e
gene
amplifi
rtpcr
sequenc
identifi
mutat
link
antibodi
escap
antibodi
bind
site
also
map
use
yeast
cell
express
librari
ediii
previous
describ
mutat
map
onto
ediii
structur
use
atom
coordin
ediii
rcsb
access
number
display
use
pymol
molecular
graphic
system
version
llc
previous
report
dengu
reactiv
memori
b
cell
common
follow
primari
secondari
denv
infect
character
human
b
cell
respons
donor
immort
memori
b
cell
pbmc
isol
igg
memori
b
cell
immort
ebv
cpg
previous
describ
immort
b
cell
cultur
supernat
screen
antibodi
bound
insect
cell
infect
thirti
five
percent
b
cell
cultur
gener
donor
posit
follow
initi
screen
tabl
dengu
posit
cultur
cultur
bound
protein
tabl
character
bind
function
properti
human
antibodi
isol
hmab
donor
isol
hmab
specif
denv
donor
posit
b
cell
cultur
clone
limit
dilut
clone
isol
expand
hybridoma
produc
singl
except
tabl
identifi
antibodi
bound
structur
viral
antigen
hmab
test
bind
purifi
particl
elisa
fourteen
hmab
bound
viru
hmab
bound
particl
crossreact
four
dengu
serotyp
dengu
complex
reactiveand
one
antibodi
hmab
bound
serotyp
dengu
sub
complex
reactiv
tabl
dengu
virion
solubil
subject
western
blot
analysi
identifi
viral
structur
protein
recogn
hmab
ten
hmab
bound
prm
singl
hmab
bound
e
protein
figur
three
hmab
bind
viral
antigen
western
blot
although
react
virion
hmab
also
test
bind
protein
elisa
hmab
also
recogn
e
protein
western
blot
bound
protein
denv
serotyp
tabl
next
test
abil
antibodi
gener
donor
neutral
denv
five
hmab
includ
two
bind
virion
lack
neutral
activ
figur
remain
antibodi
rang
weak
moder
neutral
neutral
titer
rang
figur
neutral
antibodi
similar
neutral
titer
serotyp
consist
broad
bind
specif
data
shown
gener
prm
antibodi
neutral
curv
shallow
reach
neutral
indic
fraction
viru
popul
resist
antibodi
neutral
figur
singl
e
reactiv
antibodi
exhibit
steeper
neutral
curv
neutral
viru
high
concentr
figur
summari
hmab
gener
donor
experienc
primari
infect
broadli
crossreact
weakli
neutral
mainli
direct
epitop
prm
none
hmab
mimick
function
properti
immun
serum
donor
display
strong
typespecif
neutral
tabl
complet
summari
function
profil
sixteen
hmab
donor
includ
supplementari
materi
tabl
next
character
dengu
specif
memori
b
cell
respons
donor
recov
primari
infect
previous
report
properti
b
cell
hmab
gener
donor
expand
previou
result
compar
properti
serum
antibodi
hmab
donor
epitop
map
subset
hmab
donor
immort
b
cell
cultur
supernat
donor
screen
antibodi
bound
insect
cell
infect
cultur
found
posit
denvspecif
b
cell
follow
initi
screen
tabl
denv
posit
cultur
cultur
bound
protein
tabl
thu
case
donor
although
dengu
specif
memori
b
cell
frequent
small
fraction
posit
cultur
donor
produc
antibodi
bound
protein
sinc
rel
unbias
select
scheme
produc
hmab
donor
indic
hmab
crossreact
weakli
neutral
direct
antigen
alter
select
scheme
donor
enrich
hmab
recogn
initi
screen
memori
b
cell
cultur
supernat
rel
rare
protein
bind
cultur
select
clone
expans
ten
bind
hmab
produc
antibodi
test
bind
heterolog
serotyp
hmab
typespecif
hmab
dengu
subcomplexspecif
hmab
dengu
complexspecif
figur
six
ten
hmab
bound
ediii
figur
hmab
donor
display
variabl
neutral
properti
figur
nonneutr
hmab
neutral
titer
ugml
weakli
moder
neutral
hmab
neutral
titer
ugml
strongli
neutral
hmab
neutral
titer
ugml
strongli
neutral
hmab
includ
crossreact
bind
assay
neutral
better
serotyp
figur
thu
bias
initi
screen
hmab
bound
protein
identifi
hmab
neutral
profil
similar
immun
sera
donor
strongli
neutral
sever
hmab
donor
bound
ediii
figur
two
approach
use
map
bind
site
hmab
ediii
two
strongli
neutral
hmab
bound
ediii
type
subcomplex
specif
map
identifi
neutral
escap
variant
passag
presenc
antibodi
ire
mutat
ediii
viru
passag
presenc
hmab
acquir
singl
point
mutat
tabl
figur
residu
locat
ediii
later
ridg
target
previous
map
typespecif
strongli
neutral
mous
mab
tabl
figur
viru
passag
presenc
hmab
acquir
point
mutat
tabl
figur
amino
acid
locat
strand
ediii
form
part
dengu
subcomplex
epitop
recogn
neutral
mous
mab
tabl
figur
independ
approach
map
ediiireact
hmab
use
yeast
surfac
display
assay
previous
use
map
numer
flaviviru
antibodi
tabl
summar
mutat
result
loss
bind
neutral
ediii
antibodi
gener
donor
human
ediiibind
mab
map
later
ridg
strand
region
previous
describ
target
mous
mab
figur
main
object
defin
viral
antigen
epitop
recogn
individu
expos
primari
denv
infect
subject
dengu
virion
major
target
humor
immun
respons
mani
antibodi
bind
protein
denv
virion
display
e
prm
protein
array
pseudoicosahedr
symmetri
depend
matur
state
viru
particl
e
protein
molecul
organ
headtotail
dimer
lie
flat
virion
surfac
trimer
protrud
spike
surfac
sinc
e
protein
amino
acid
consider
larger
amino
acid
prm
protein
major
surfac
expos
viral
protein
consist
ectodomain
e
thu
find
mani
antibodi
bound
epitop
viru
preserv
somewhat
unexpect
find
consist
result
anoth
studi
group
well
studi
dejnirattisai
colleagu
observ
mani
hmab
bound
denv
particl
bind
protein
protein
use
current
studi
lack
protein
includ
membran
proxim
region
transmembran
domain
possibl
antibodi
bind
region
moreov
antibodi
may
recogn
e
protein
epitop
avail
context
nativ
oligomer
array
virion
sever
hmab
gener
individu
infect
west
nile
viru
bound
virion
protein
hmab
recogn
epitop
creat
adjac
e
protein
molecul
surfac
virion
form
hing
region
produc
mab
donor
increas
probabl
identifi
strongli
neutral
antibodi
bias
select
scheme
mab
specif
recogn
protein
contrast
weak
nonneutr
hmab
isol
donor
sever
hmab
donor
display
strong
typespecif
neutral
note
even
hmab
donor
bound
one
serotyp
dengu
subcomplex
complex
mab
display
typespecif
neutral
serotyp
infect
donor
thu
bias
select
enrich
rare
protein
bind
antibodi
gener
hmab
donor
function
similar
polyclon
immun
serum
donor
neutral
unclear
result
hmab
relat
neutral
properti
polyclon
immun
serum
donor
one
possibl
abund
hmab
reflect
function
properti
antibodi
immun
sera
small
fraction
denvspecif
antibodi
immun
sera
respons
neutral
altern
conceiv
individu
antibodi
weakli
neutral
becom
strongli
neutral
due
cooper
effect
occur
polyclon
milieu
studi
need
understand
properti
hmab
denv
immun
donor
relat
properti
circul
serum
antibodi
neutral
mab
donor
bound
bound
later
ridg
strand
epitop
ediii
ref
also
identifi
sever
neutral
hmab
bound
ediii
antibodi
like
bind
epitop
edi
edii
especi
interest
map
bind
site
hmab
recent
studi
indic
epitop
later
ridg
strand
ediii
target
strongli
neutral
mous
hors
primat
antibodi
result
indic
prm
domin
target
primari
antibodi
respons
agreement
recent
studi
prm
protein
requir
proper
fold
assembl
flaviviru
particl
endoplasm
reticulum
also
prevent
adventiti
fusion
viru
acid
environ
transgolgi
network
recent
studi
demonstr
denv
virion
produc
cell
cultur
often
partial
process
contain
mixtur
unprocess
prm
fulli
process
matur
state
rel
amount
prm
virion
alter
potenc
antibodi
bind
specif
epitop
e
includ
crossreact
antibodi
bind
fusion
loop
dii
addit
immatur
noninfecti
particl
becam
infecti
presenc
prm
antibodi
enhanc
abil
immatur
dengu
virion
infect
fcreceptor
bear
cell
vitro
given
find
other
establish
prm
antibodi
common
follow
primari
secondari
denv
infect
work
need
perform
address
contribut
dengu
pathogenesi
human
summari
studi
report
demonstr
unexpect
antibodi
profil
two
individu
follow
primari
dengu
infect
individu
major
denvspecif
human
antibodi
broadli
crossreact
weakli
neutral
mani
antibodi
bound
prm
site
viru
preserv
protein
minor
fraction
total
dengu
specif
antibodi
respons
respons
potent
neutral
homolog
viru
given
difficulti
identifi
suitabl
donor
gener
antigen
specif
hmab
character
antibodi
respons
two
subject
studi
dengu
immun
subject
need
determin
find
broadli
applic
primari
dengu
exposur
